Kwality Pharmaceuticals Limited has scheduled a meeting of its Board of Directors to be held on Monday, August 10, 2026 at the registered office of the Company situated at Village Nagkalan, Majitha Road, Amritsar, Punjab-143601. The meeting will commence at 10:30 A.M.
The primary agenda of the board meeting is to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended on 30th June, 2026 (Q1 FY2027).
Additionally, the company confirms the continuation of the trading window closure that was previously intimated on June 29, 2026. The Trading Window for dealing in the shares of the Company for all designated persons, their immediate relatives and other connected person(s) shall remain closed until 48 hours after the declaration of Financial Results of the Company on August 10, 2026.
Financial impact of the results is not quantified in this disclosure as the meeting is yet to be held and the results are pending approval.